BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1090336)

  • 1. Immune complexes in cystic fibrosis.
    McFarlane H; Holzel A; Brenchley P; Allan JD; Wallwork JC; Singer BE; Worsley B
    Br Med J; 1975 Feb; 1(5955):423-8. PubMed ID: 1090336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.
    Van Bever HP; Gigase PL; De Clerck LS; Bridts CH; Franckx H; Stevens WJ
    Arch Dis Child; 1988 Oct; 63(10):1222-8. PubMed ID: 3143315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of Pseudomonas aeruginosa with immunoglobulins and complement in sputum.
    Hann S; Holsclaw DS
    Infect Immun; 1976 Jul; 14(1):114-7. PubMed ID: 820637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
    Schiøtz PO; Høiby N; Permin H; Wiik A
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of circulating immune complexes in patients with cystic fibrosis and arthritis.
    Wulffraat NM; de Graeff-Meeder ER; Rijkers GT; van der Laag H; Kuis W
    J Pediatr; 1994 Sep; 125(3):374-8. PubMed ID: 8071744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating soluble immune complexes containing pseudomonas antigens in cystic fibrosis.
    Pitcher-Wilmott RW; Levinsky RJ; Matthew DJ
    Arch Dis Child; 1982 Aug; 57(8):577-81. PubMed ID: 6810763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Some aspects of immunity in patients with cystic fibrosis.
    Wallwork JC; Brenchley P; McCarthy J; Allan JD; Moss D; Ward AM; Holzel A; Williams RF; McFarlane H
    Clin Exp Immunol; 1974 Nov; 18(3):303-20. PubMed ID: 4219907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies in serum and sputum from patients with cystic fibrosis.
    Schiøtz PO; Egeskjold EM; Høiby N; Permin H
    Acta Pathol Microbiol Scand C; 1979 Oct; 87(5):319-24. PubMed ID: 117671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating immune complexes and the nephropathy of cystic fibrosis.
    Davis CA; Abramowsky CR; Swinehart G
    Hum Pathol; 1984 Mar; 15(3):244-7. PubMed ID: 6365737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
    Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
    J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of circulating immune complexes in cystic fibrosis.
    Moss RB; Hsu YP
    Clin Exp Immunol; 1982 Feb; 47(2):301-8. PubMed ID: 6804143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic significance of the secretory A immunoglobulins.
    Bellanti JA
    Pediatrics; 1971 Nov; 48(5):715-29. PubMed ID: 4256343
    [No Abstract]   [Full Text] [Related]  

  • 14. Lipopolysaccharide is present in immune complexes isolated from sputum in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G; Shand GH; Fomsgaard A; Høiby N
    APMIS; 1992 Feb; 100(2):175-80. PubMed ID: 1554493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The precipitins and hypersensitivity reactions in cystic fibrosis.
    McFarlene H; Allan JD; Malhotra A; Hozel A; Wallwork JC
    Compr Ther; 1978 Apr; 4(4):61-7. PubMed ID: 348396
    [No Abstract]   [Full Text] [Related]  

  • 16. Relationship of hypergammaglobulinemia, circulating immune complexes, and histocompatibility antigen profiles in patients with cystic fibrosis.
    Jones MM; Seilheimer DK; Pollack MS; Curry M; Crane MM; Rossen RD
    Am Rev Respir Dis; 1989 Dec; 140(6):1636-9. PubMed ID: 2604292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating immune complexes in cystic fibrosis.
    Manthei U; Taussig LM; Beckerman RC; Strunk RC
    Am Rev Respir Dis; 1982 Aug; 126(2):253-7. PubMed ID: 7103251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune complexes and complement abnormalities in patients with cystic fibrosis. Increased mortality associated with circulating immune complexes and decreased function of the alternative complement pathway.
    Wisnieski JJ; Todd EW; Fuller RK; Jones PK; Dearborn DG; Boat TF; Naff GB
    Am Rev Respir Dis; 1985 Oct; 132(4):770-6. PubMed ID: 3850731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.
    Moss RB; Lewiston NJ
    Am Rev Respir Dis; 1980 Jan; 121(1):23-9. PubMed ID: 6766286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulins and albumin in sputum from patients with cystic fibrosis. A study of protein stability and presence of proteases.
    Schiøtz PO; Clemmensen I; Høiby N
    Acta Pathol Microbiol Scand C; 1980 Oct; 88(5):275-80. PubMed ID: 7008501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.